After obtaining a Chemistry and a Biochemistry Degree from the University of Salamanca and a Molecular Biotechnology Master’s Degree from the University of Barcelona, Roldán decided he wanted to study tumor metabolism in order to find new diagnostic methods and therapeutic approaches to fight cancer. In 2014 he obtained a PhD in Molecular Biology with a focus in cancer metabolomics in the University of Barcelona, and subsequently he worked as a Post-Doc Researcher, Project Manager and Assistant Professor in the University of Barcelona.
During his years of experience in scientific research, Roldán acquired expertise not only in the molecular study of cancer and in many different biochemical analysis techniques, but also in setting up new methods and workflows, supervising junior scientists and coordinating both public and privately founded academic-industry collaborative projects.
In 2016 he started a Master’s Degree in Medical Studies Monitoring by the Barcelona Official College of Physicians, and in 2017 he joined MedSIR fascinated by the company’s approach to strategically-designed, patient-centered, investigator-driven clinical trials in oncology. His expertise in health sciences, his passion about translational medical research and his experience with multidisciplinary projects make him an ideal addition to MedSIR’s team, and a fierce enthusiast of our vision of developing innovative ways to improve the lives of cancer patients worldwide.
Roldán speaks English, Spanish, and Catalan fluently.